ClearSign Technologies (CLIR) 10-K 11 Mar 14 2013 FY Annual report Financial data

Document_And_Entity_Informatio

Document And Entity Information (USD $)	12 Months Ended
	Dec. 31, 2013	Mar. 11, 2014	Jun. 30, 2013
Document Information [Line Items]	'	'	'
Entity Registrant Name	'CLEARSIGN COMBUSTION CORP	'	'
Entity Central Index Key	'0001434524	'	'
Current Fiscal Year End Date	'--12-31	'	'
Entity Filer Category	'Smaller Reporting Company	'	'
Trading Symbol	'CLIR	'	'
Entity Common Stock, Shares Outstanding	'	9,648,134	'
Document Type	'10-K	'	'
Amendment Flag	'false	'	'
Document Period End Date	31-Dec-13	'	'
Document Fiscal Period Focus	'FY	'	'
Document Fiscal Year Focus	'2013	'	'
Entity Well-known Seasoned Issuer	'No	'	'
Entity Voluntary Filers	'No	'	'
Entity Current Reporting Status	'Yes	'	'
Entity Public Float	'	'	$59,800,000

Balance_Sheets

Balance Sheets (USD $)	Dec. 31, 2013	Dec. 31, 2012
ASSETS	'	'
Cash and cash equivalents	$2,688,000	$8,027,000
Prepaid expenses	118,000	60,000
Total current assets	2,806,000	8,087,000
Fixed assets, net	427,000	400,000
Patents and other intangible assets	1,459,000	618,000
Other assets	10,000	10,000
Total Assets	4,702,000	9,115,000
LIABILITIES AND STOCKHOLDERS' EQUITY	'	'
Accounts payable	297,000	276,000
Accrued compensation and taxes	586,000	168,000
Total current liabilities	883,000	444,000
Deferred rent	31,000	35,000
Total liabilities	914,000	479,000
Commitments and Contingencies	'	'
Stockholders' Equity:	'	'
Preferred stock, $0.0001 par value, zero shares issued and outstanding	0	0
Common stock, $0.0001 par value, 8,810,674 and 8,752,015 shares issued and outstanding at December 31, 2013 and 2012, respectively	1,000	1,000
Additional paid-in capital	17,751,000	17,314,000
Deficit accumulated in the development stage	-13,964,000	-8,679,000
Total stockholders' equity	3,788,000	8,636,000
Total Liabilities and Stockholders' Equity	$4,702,000	$9,115,000

Balance_Sheets_Parenthetical

Balance Sheets [Parenthetical] (USD $)	Dec. 31, 2013	Dec. 31, 2012
Preferred stock, par value (in dollars per share)	$0.00	$0.00
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value (in dollars per share)	$0.00	$0.00
Common stock, shares issued	8,810,674	8,752,015
Common stock, shares outstanding	8,810,674	8,752,015

Statements_of_Operations

Statements of Operations (USD $)	12 Months Ended		71 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013
Co-development revenue	$93,000	$0	$93,000
Cost of co-development revenue	88,000	0	88,000
Gross profit	5,000	0	5,000
Operating expenses:	'	'	'
Research and development	1,851,000	1,184,000	3,559,000
General and administrative	3,450,000	3,026,000	10,446,000
Total operating expenses	5,301,000	4,210,000	14,005,000
Loss from operations	-5,296,000	-4,210,000	-14,000,000
Other income (expense):	'	'	'
Interest income	11,000	22,000	37,000
Interest expense	0	-1,000	-1,000
Total other income (expense)	11,000	21,000	36,000
Net Loss	($5,285,000)	($4,189,000)	($13,964,000)
Net Loss per share - basic and fully diluted (in dollars per share)	($0.60)	($0.55)	($3.02)
Weighted average number of shares outstanding - basic and fully diluted (in shares)	8,795,810	7,596,962	4,618,583

Statement_of_Stockholders_Equi

Statement of Stockholders' Equity (Deficit) (USD $)	Total	Common Stock [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Accumulated Deficit during Development Stage [Member]
			Common Class B [Member]
Balances at Jan. 22, 2008	'	'	'	'	'
Shares issued to founders, at no cost	33,000	0	0	33,000	0
Shares issued to founders, at no cost (in shares)	'	1,065,000	476,000	'	'
Shares issued for services ($0.02 per share)	2,000	0	0	2,000	0
Shares issued for services ($0.02 per share) (in shares)	'	125,000	0	'	'
Shares issued for cash ($0.02 per share)	10,000	0	0	10,000	0
Shares issued for cash ($0.02 per share) (in shares)	'	0	384,000	'	'
Shares issued for cash ($1.80 per share)	841,000	0	0	841,000	0
Shares issued for cash ($1.80 per share) (in shares)	'	467,310	0	'	'
Shares issued for services ($1.80 per share)	264,000	0	0	264,000	0
Shares issued for services ($1.80 per share) (in shares)	'	146,644	0	'	'
Conversion of shares	0	0	0	0	0
Conversion of shares (in shares)	'	1,075,000	-860,000	'	'
Shares issued for cash ($2.20 per share)	2,999,000	0	0	2,999,000	0
Shares issued for cash ($2.20 per share) (in shares)	'	1,363,364	0	'	'
Shares issued for services ($2.20 per share)	1,614,000	0	0	1,614,000	0
Shares issued for services ($2.20 per share) (in shares)	'	733,523	0	'	'
Issuance costs	-813,000	0	0	-813,000	0
Share based payments of warrants	112,000	0	0	112,000	0
Share based compensation	302,000	0	0	302,000	0
Share based compensation (in shares)	'	177,375	0	'	'
Net loss	-4,490,000	0	0	0	-4,490,000
Balances at Dec. 31, 2011	874,000	0	0	5,364,000	-4,490,000
Balances (in shares) at Dec. 31, 2011	'	5,153,216	0	'	'
Shares issued in initial public offering ($4.00 per share)	13,800,000	1,000	0	13,799,000	0
Shares issued in initial public offering ($4.00 per share) (in shares)	'	3,450,000	0	'	'
Issuance costs of initial public offering	-2,727,000	0	0	-2,727,000	0
Share based payments of warrants	128,000	0	0	128,000	0
Shares issued for services ($4.00 per share)	72,000	0	0	72,000	0
Shares issued for services ($4.00 per share) (in shares)	'	18,000	0	'	'
Shares issued for services ($4.94 per share)	103,000	0	0	103,000	0
Shares issued for services ($4.94 per share) (in shares)	20,799	20,799	0	'	'
Shares issued to retire payable ($4.00 per share)	440,000	0	0	440,000	0
Shares issued to retire payable ($4.00 per share) (in shares)	'	110,000	0	'	'
Share based compensation	135,000	0	0	135,000	0
Share based compensation (in shares)	'	0	0	'	'
Net loss	-4,189,000	0	0	0	-4,189,000
Balances at Dec. 31, 2012	8,636,000	1,000	0	17,314,000	-8,679,000
Balances (in shares) at Dec. 31, 2012	'	8,752,015	0	'	'
Shares issued in initial public offering ($4.00 per share)	13,800,000	'	'	'	'
Shares issued for services ($5.00 per share)	150,000	0	0	150,000	0
Shares issued for services ($5.00 per share) (in shares)	30,000	30,000	0	'	'
Shares issued for services ($9.12 per share)	102,000	0	0	102,000	0
Shares issued for services ($9.12 per share) (in shares)	'	11,250	0	'	'
Shares issued upon exercise of warrant ($2.20 per share)	39,000	0	0	39,000	0
Shares issued upon exercise of warrant ($2.20 per share) (in shares)	'	17,409	0	'	'
Share based compensation	146,000	0	0	146,000	0
Share based compensation (in shares)	'	0	0	'	'
Net loss	-5,285,000	0	0	0	-5,285,000
Balances at Dec. 31, 2013	$3,788,000	$1,000	$0	$17,751,000	($13,964,000)
Balances (in shares) at Dec. 31, 2013	'	8,810,674	0	'	'

Statement_of_Stockholders_Equi1

Statement of Stockholders' Equity (Deficit) [Parenthetical] (USD $)	12 Months Ended		47 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Par value of common stock issued for services one	'	'	$0.02
Par value of common stock issued one	'	'	$0.02
Par value of common stock issued two	'	'	$1.80
Par value of common stock issued three	'	'	$2.20
Par value of shares issued in initial public offering	$4	$4	'
Par value of common stock issued for services two	'	'	$1.80
Par value of common stock issued for services three	'	'	$2.20
Par value of common stock issued for services four	'	$4	'
Par value of common stock issued for services five	'	$4.94	'
Par value of shares issued to retire payable	'	$4	'
Par value of common stock issued for services six	$5	$4.94	'
Par value of common stock issued for services Seven	$9.12	'	'
Par value of common stock issued Exercise Of Warrant	$2.20	'	'

Statements_of_Cash_Flows

Statements of Cash Flows (USD $)	12 Months Ended		71 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013
Cash flows from operating activities:	'	'	'
Net loss	($5,285,000)	($4,189,000)	($13,964,000)
Adjustments to reconcile net loss to net cash used in operating activities:	'	'	'
Common stock issued or issuable for services	252,000	175,000	1,781,000
Share based payments	146,000	135,000	468,000
Depreciation	209,000	99,000	366,000
Abandonment of capitalized patent	4,000	0	4,000
Deferred rent	-4,000	17,000	31,000
Change in operating assets and liabilities:	'	'	'
Prepaid expenses	-58,000	377,000	-118,000
Other assets	0	10,000	-10,000
Accounts payable	21,000	274,000	791,000
Accrued compensation	418,000	-86,000	701,000
Net cash used in operating activities	-4,297,000	-3,188,000	-9,950,000
Cash flows from investing activities:	'	'	'
Acquisition of fixed assets	-236,000	-337,000	-772,000
Disbursements for patents and other intangible assets	-845,000	-531,000	-1,463,000
Net cash used in investing activities	-1,081,000	-868,000	-2,235,000
Cash flows from financing activities:	'	'	'
Proceeds from issuance of common stock for cash, net of offering costs	39,000	11,201,000	14,921,000
Proceeds from issuance of short term promissory note	0	98,000	98,000
Principal payments on promissory notes	0	-146,000	-146,000
Net cash provided by financing activities	39,000	11,153,000	14,873,000
Net increase (decrease) in cash and cash equivalents	-5,339,000	7,097,000	2,688,000
Cash and cash equivalents, beginning of period	8,027,000	930,000	0
Cash and cash equivalents, end of period	2,688,000	8,027,000	2,688,000
Supplemental disclosure of cash flow information:	'	'	'
Cash paid during the period for interest	$0	$1,000	$1,000

Supplemental_disclosure_of_non

Supplemental disclosure of non-cash investing and financing activities (USD $)

12 Months Ended

47 Months Ended

12 Months Ended

47 Months Ended

12 Months Ended

47 Months Ended

12 Months Ended

47 Months Ended

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2011

Dec. 31, 2011

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2011

Dec. 31, 2011

Dec. 31, 2012

Dec. 31, 2011

Issue One [Member]

Issue Two [Member]

Consultant [Member]

Consultant [Member]

Directors [Member]

Directors [Member]

MDB Capital Group LLC [Member]

Common Stock [Member]

Common Stock [Member]

Common Stock Offering [Member]

Common Class B [Member]

Common Class B [Member]

Common Class B [Member]

Common Stock [Member]

Common Stock [Member]

Number Of Stock To Be Issued Upon Conversion Of Warrants (in shares)

'

'

'

'

'

'

'

'

'

'

'

136,368

'

'

'

Warrants Authorized For Issuance To Acquire Common Stock Shares Number (in shares)

345,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Share based payments of warrants

$128,000

$112,000

'

'

'

'

'

'

'

$0

$0

'

'

$0

$0

Debt Conversion, Converted Instrument, Shares Issued (in shares)

'

'

'

'

'

'

'

'

'

110,000

3,555

'

'

'

'

Common stock issued in partial satisfaction of accounts payable

440,000

8,000

'

'

'

'

'

'

'

'

'

'

'

'

'

Stock Issued During Period, Shares, Issued for Services (in shares)

'

2,000

'

'

11,250

18,000

30,000

20,799

454,547

'

'

'

'

'

'

Stock Issued During Period, Value, Issued for Services

'

4,000

'

'

102,000

72,000

150,000

103,000

1,000,000

'

'

'

'

'

'

Common stock issued for issuance costs

'

'

'

'

'

'

'

'

'

'

'

580,000

'

'

'

Common stock issued, shares (in shares)

'

68,091

'

'

'

'

'

'

'

'

'

'

'

'

'

Stock issued

'

126,000

'

'

'

'

'

'

'

'

'

'

'

'

'

Common stock shares issued to discharge common stock to be issued (in shares)

'

49,728

'

'

'

'

'

'

'

'

'

'

'

'

'

Common stock shares cancelled (in shares)

'

5,825

'

'

'

'

'

'

'

'

'

'

'

'

'

Common stock value cancelled

'

10,000

'

'

'

'

'

'

'

'

'

'

'

'

'

Common stock shares swapped (in shares)

'

'

'

'

'

'

'

'

'

'

'

'

860,000

'

'

Common stock shares held by founders (in shares)

'

'

'

'

'

'

'

'

'

'

'

'

1,075,000

'

'

Common Stock Share Issued To Partially Satisfy Compensation (in shares)

'

52,375

'

'

'

'

'

'

'

'

'

'

'

'

'

Common stock value issued to partially satisfy compensation

'

115,000

'

'

'

'

'

'

'

'

'

'

'

'

'

Accounts payable to vendors

'

46,000

'

'

'

'

'

'

'

'

'

'

'

'

'

Fair value of assets acquired

'

2,000

'

'

'

'

'

'

'

'

'

'

'

'

'

Interest Bearing Promissory Note

'

48,000

'

'

'

'

'

'

'

'

'

'

'

'

'

Warrants Issued During Period Value

'

'

'

'

'

'

'

'

'

'

'

64,000

'

'

'

Stock Issued During Period, Shares, Other (in shares)

'

10,834

'

'

'

'

'

'

'

'

'

'

'

'

'

Stock Issued During Period, Value, Other

'

20,000

'

'

'

'

'

'

'

'

'

'

'

'

'

Common Stock Value Issued To Discharge Common Stock To Be Issued One

'

99,000

'

'

'

'

'

'

'

'

'

'

'

'

'

Common Stock Value Issued To Discharge Common Stock To Be Issued Two

'

90,000

'

'

'

'

'

'

'

'

'

'

'

'

'

Share Based Compensation Arrangement By Share Based Payment Award Shares Issued (in shares)

'

'

50,000

75,000

'

'

'

'

'

'

'

'

'

'

'

Stock Granted During Period, Value, Share-based Compensation, Gross

'

$275,000

'

'

'

'

'

'

'

'

'

'

'

'

'

Initial Public Offering For Under writing Fee

'

'

'

'

'

'

'

'

'

'

'

263,637

'

'

'

Organization_and_Description_o

Organization and Description of Business	12 Months Ended
	Dec. 31, 2013
Accounting Policies [Abstract]	'
Organization, Consolidation, Basis Of Presentation, Business Description and Accounting Policies [Text Block]	'
	Note 1 – Organization and Description of Business
	ClearSign Combustion Corporation (ClearSign or the Company) is a development stage company located in Seattle, Washington and incorporated in the state of Washington on January 23, 2008. The Company was formed to design, develop and market technologies that improve both the energy efficiency and emission control characteristics of combustion systems. The Company’s primary technologies include its Electrodynamic Combustion Control™ or ECC™ technology, which introduces a computer-controlled electric field into the combustion region which may better control gas-phase chemical reactions and improve system performance and cost-effectiveness, and its Duplex™ technology, which achieves very low emissions without the need of external flue gas recirculation, selective catalytic reduction, or higher excess air operation.
	As a development stage company, the Company has generated limited revenues from operations to date to meet its operating expenses, and has historically financed its operations primarily through issuances of equity securities. The Company has incurred losses since its inception totaling $13,964,000 and expects to experience operating losses and negative cash flow for the foreseeable future. Management believes that the successful growth and operation of the Company’s business is dependent upon its ability to obtain adequate sources of funding through co-development agreements, strategic partnering agreements, or equity or debt financing to adequately support research and development efforts, protect intellectual property, form relationships with strategic partners, and provide for working capital and general corporate purposes. There can be no assurance that the Company will be successful in achieving its long-term plans as set forth above, or that such plans, if consummated, will enable the Company to obtain profitable operations or continue in the long-term as a going concern.

Summary_of_Significant_Account

Summary of Significant Accounting Policies	12 Months Ended
	Dec. 31, 2013
Accounting Policies [Abstract]	'
Significant Accounting Policies [Text Block]	'
	Note 2 – Summary of Significant Accounting Policies
	Development Stage Enterprise
	The Company is a development stage company as defined in Financial Accounting Standards Board (FASB) Accounting Standards Codification (ASC) 915, Development Stage Entities. The Company is devoting substantially all of its present efforts to design and develop new technologies in combustion systems and its planned principal operations have not yet commenced. The Company has not generated any significant revenues from operations and has no assurance of any future revenues. All losses accumulated since January 23, 2008 have been considered as part of the Company's development stage activities.
	Use of Estimates
	The preparation of financial statements in conformity with accounting principles generally accepted in the United States (US GAAP) requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
	Revenue Recognition
	The Company recognizes revenue on co-development agreements using the percentage of completion method. Under this method, the completion percentage is determined by dividing costs incurred to date by total estimated project costs. Since these projects will require technological development to complete, which by its nature is difficult to predict, the actual cost required to complete contracted work may vary from estimates. Estimated project costs are revised regularly which can alter the reported level of project profitability. Any estimated project losses are recognized in the current reporting period. Customer billings are recorded when cash receipts are probable and in accordance with the underlying co-development contract. If billings exceed recognized revenue, the difference is recorded as a current liability, while any recognized revenues exceeding billings are recorded as a current asset. Recognized revenues are subject to revisions as the contract progresses to completion and actual revenue and cost become certain. Revisions in revenue estimates are reflected in the period in which the facts that give rise to the revision become known.
	Cost of Revenue
	Cost of co-development revenue includes both direct and allocated indirect costs of completing the scope of work of co-development agreements. Direct costs include labor, materials and other costs incurred directly in fulfilling co-development agreements. Indirect costs include labor, rent, depreciation and other costs associated with operating the Company. Due to the nature of the work involved, the cost of co-development projects may fluctuate substantially from period to period.
	Cash and Cash Equivalents
	Highly liquid investments purchased with an original maturity of three months or less are considered cash equivalents. Cash is maintained with a commercial bank where accounts are generally guaranteed by the Federal Deposit Insurance Corporation up to $250,000. The Company’s deposits exceed this limit. The Company has not experienced losses in such accounts and believes it is not exposed to any significant credit risk on cash and cash equivalents.
	Fixed Assets
	Fixed assets are recorded at cost.  Depreciation is computed using the straight-line method over the estimated lives of the respective assets. Leasehold improvements are depreciated over the life of the lease or their useful life, whichever is shorter. All other fixed assets are depreciated over three to four years. Maintenance and repairs are expensed as incurred.
	Patents and Trademarks
	Patents and trademarks are recorded at cost. Amortization is computed using the straight-line method over the estimated useful lives of the assets once they are awarded, which has not yet occurred.
	Impairment of Long-Lived Assets
	The Company tests long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable through the estimated undiscounted cash flows expected to result from the use and eventual disposition of the assets. In that event, a loss is recognized based on the amount by which the carrying amount exceeds the fair value of the long-lived assets. Loss on long-lived assets to be disposed of is determined in a similar manner, except that fair values are reduced for the cost of disposal. During 2013, the Company recorded an impairment loss of $4,000 from abandonment of a capitalized patent. As of December 31, 2012, the Company determined that there was no impairment.
	Fair Value of Financial Instruments
	Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Assets and liabilities measured at fair value are categorized based on whether or not the inputs are observable in the market and the degree that the inputs are observable. The categorization of financial assets and liabilities within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement.
	The Company's financial instruments primarily consist of cash and cash equivalents, accounts payable and accrued expenses. As of the balance sheet dates, the estimated fair values of the financial instruments were not materially different from their carrying values as presented on the balance sheets. This is primarily attributed to the short maturities of these instruments. The Company did not identify any other non-recurring assets and liabilities that are required to be presented in the balance sheets at fair value.
	Research and Development
	The cost of research and development is expensed as incurred. Research and development costs consist of salaries, benefits, share based compensation, consulting fees, rent, utilities, depreciation, and consumables.
	Deferred Rent
	Operating lease agreements which contain provisions for future rent increases or periods in which rent payments are reduced or abated are recorded in monthly rent expense in the amount of the total payments over the lease term divided by the number of months of the lease term. The difference between rent expense recorded and the amount paid is credited or charged to deferred rent which is reflected on the accompanying balance sheet.
	Income Taxes
	The Company accounts for income taxes using an asset and liability approach which allows for the recognition and measurement of deferred tax assets based upon the likelihood of realization of tax benefits in future years. Under the asset and liability approach, deferred taxes are provided for the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. A valuation allowance is provided for deferred tax assets if it is more likely than not these items will either expire before the Company is able to realize their benefits, or that future deductibility is uncertain.
	Tax benefits from an uncertain tax position are recognized only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities based on the technical merits of the position. The tax benefits recognized in the financial statements from such a position are measured based on the largest benefit that has a greater than 50 percent likelihood of being realized upon ultimate resolution.
	Stock-Based Compensation
	The costs of all employee stock options, as well as other equity-based compensation arrangements, are reflected in the financial statements based on the estimated fair value of the awards on the grant date. That cost is recognized over the period during which an employee is required to provide service in exchange for the award. Stock compensation for stock granted to non-employees is determined as the fair value of the consideration received or the fair value of equity instruments issued, whichever is more reliably measured.
	Net Loss per Common Share
	Basic loss per share is computed by dividing loss available to common stockholders by the weighted-average number of common shares outstanding. Diluted loss per share is computed similar to basic loss per share except that the denominator is increased to include additional common shares available upon exercise of stock options and warrants using the treasury stock method, except for periods for which no common share equivalents are included because their effect would be anti-dilutive. Potentially dilutive shares outstanding amounted to 1,109,724 and 920,743 at December 31, 2013 and 2012, respectively.
	Recently Issued Accounting Pronouncements
	Management does not believe that any recently issued, but not yet effective standards, if adopted, will have a material effect on the financial statements.
	Emerging Growth Company
	The Company is an emerging growth company as defined under the Jumpstart Our Business Startups Act of 2012 (JOBS Act).  An emerging growth company may delay the adoption of certain accounting standards until those standards would otherwise apply to private companies.  The Company will remain an emerging growth company until December 31, 2017, although it will lose that status sooner if its revenues exceed $1 billion, if it issues more than $1 billion in non-convertible debt in a three year period, or if the market value of its common stock that is held by non-affiliates exceeds $700 million as of any June 30. At June 30, 2013, the market value of the Company’s common stock that is held by non-affiliates totaled $60 million.

Fixed_Assets

Fixed Assets	12 Months Ended
	Dec. 31, 2013
Property, Plant and Equipment [Abstract]	'
Property, Plant and Equipment Disclosure [Text Block]	'
	Note 3 – Fixed Assets
	Fixed assets are summarized as follows:
		December 31,
		2013		2012
	Machinery and equipment	$	633,000	$	444,000
	Office furniture and equipment		95,000		71,000
	Leasehold improvements		62,000		29,000
	Accumulated depreciation		-366,000		-157,000
			424,000		387,000
	Construction in progress		3,000		13,000
		$	427,000	$	400,000

Promissory_Notes

Promissory Notes	12 Months Ended
	Dec. 31, 2013
Debt Disclosure [Abstract]	'
Debt Disclosure [Text Block]	'
	Note 4 – Promissory Notes
	In December 2011, the Company executed a $48,000 promissory note with a vendor to extend the terms of an account payable. The fully amortizing unsecured note bore interest at 8% per annum and was payable in equal monthly payments of $4,000 through its maturity in November 2012. The Company paid the note in full without penalty in May 2012.
	In April 2012, the Company executed a $98,000 promissory note to finance certain insurance coverage. The fully amortizing unsecured note bore interest at 3.39% per annum and was payable in equal monthly payments of $11,000 through its maturity in January 2013. The Company paid the note in full without penalty in May 2012.

Income_Taxes

Income Taxes	12 Months Ended
	Dec. 31, 2013
Income Tax Disclosure [Abstract]	'
Income Tax Disclosure [Text Block]	'
	Note 5 – Income Taxes
	Through December 31, 2013, the Company incurred net operating losses for federal tax purposes of approximately $14,100,000. The net operating loss carry forward may be used to reduce taxable income through the years 2028 to 2033. The availability of the Company's net operating loss carry forward is subject to limitation if there is a 50% or more change in the ownership of the Company's stock.
	A reconciliation of the expected tax computed at the statutory federal income tax rate to the provision for income taxes is as follows:
		2013		2012
	Expected tax benefit at 34%	$	-1,797,000	$	-1,424,000
	Change in valuation allowance		1,720,000		1,675,000
	Other		77,000		-251,000
	Provision for income taxes	$	-	$	-
	The net deferred tax asset at December 31, 2013 and 2012 was $4,795,000 and $3,075,000, respectively. A 100% valuation allowance has been established against the deferred tax assets as the utilization of the loss carry forward cannot reasonably be assured. Significant components of the deferred tax assets (liabilities), computed at the statutory federal tax rate of 34%, are approximately as follows:
		2013		2012
	Net operating loss carry forwards	$	4,800,000	$	3,020,000
	Accrued liabilities		-25,000		-20,000
	Stock compensation		-65,000		-15,000
	Depreciation		75,000		80,000
	Prepaid expenses		20,000		20,000
	Deferred rent		-10,000		-10,000
	Deferred tax assets, net		4,795,000		3,075,000
	Valuation allowance		-4,795,000		-3,075,000
	Net deferred tax asset	$	-	$	-
	Although the Company is not under examination, the tax years for 2008 and forward are subject to examination by United States tax authorities. The Company’s practice is to recognize interest and penalties related to income tax matters in income tax expense. As of December 31, 2013 and 2012, there was no accrued interest or penalties related to uncertain tax positions.

Stockholders_Equity

Stockholders' Equity	12 Months Ended
	Dec. 31, 2013
Stockholders' Equity Note [Abstract]	'
Stockholders' Equity Note Disclosure [Text Block]	'
	Note 6 – Stockholders’ Equity
	Common Stock and Preferred Stock
	The Company is authorized to issue 62,500,000 shares of common stock and 2,000,000 shares of preferred stock. Preferences, limitations, voting powers and relative rights of any preferred stock to be issued may be determined by the Company’s Board of Directors. The Company has not issued any shares of preferred stock.
	In April and May 2012, the Company completed an initial public offering (IPO) whereby 3,450,000 shares of common stock were issued at $4.00 per share, which included the exercise of the overallotment allowance by the underwriter, MDB Capital Group, LLC (MDB). Gross proceeds from the IPO totaled $13.8 million and net cash proceeds approximated $11.2 million. Expenses of the offering approximated $2.7 million, including underwriter fees of $1.2 million paid to MDB along with a warrant to purchase 345,000 shares of ClearSign’s common stock at $5.00 per share exercisable from April 2013 to April 2017 valued at $128,000, qualified independent underwriter fees of $110,000, underwriter legal fees of $125,000, underwriter expenses of $35,000, and issuer legal fees of $822,000, which was paid in part through the issuance of 110,000 shares of the Company’s common stock to its legal counsel at a price of $4.00 per share.
	As described in Note 10, the Company completed a $6.5 million registered direct offering of common stock in March 2014.
	Equity Incentive Plan
	The Company has an Equity Incentive Plan which provides for the granting of options to purchase shares of common stock, stock awards to purchase shares at no less than 85% of the value of the shares, and stock bonuses to officers, employees, board members, certain consultants, and advisors. The Compensation Committee of the Board of Directors is authorized to administer the Equity Incentive Plan and establish the grant terms, including the grant price, vesting period and exercise date. As of December 31, 2013, the number of shares reserved for issuance under the Equity Incentive Plan totaled 991,300 shares. The Equity Incentive Plan provides for quarterly increases in the available number of authorized shares equal to the lesser of 10% of any new shares issued by the Company during the quarter immediately prior to the adjustment date or such lesser amount as the Board of Directors shall determine.  Activity under the Equity Incentive Plan is as follows:
			2013		2012
	Reserved but unissued shares under the Equity Incentive Plan, beginning of year		480,260		140,625
	Increases in the number of authorized shares under the Equity Incentive Plan		5,866		360,434
	Grants of stock options		-206,390		-
	Stock option forfeitures		-		-
	Stock grants		-30,000		-83,299
	Stock grant forfeitures		-		62,500
	Reserved but unissued shares under the Equity Incentive Plan, end of year		249,736		480,260
	Stock Options
	In 2013, the Company granted to certain employees 203,990 and 2,400 stock options at an exercise prices of $4.88 per share and $7.33 per share, respectively, under the Equity Incentive Plan. The stock options were issued at the grant date fair value for a contractual life of 10 years and vest over four years. As permitted by SAB 107, due to the Company’s insufficient history of option activity, management utilized the simplified approach to estimate the options’ expected term, which represents the period of time that options granted are expected to be outstanding. Expected volatility was determined through the average of a peer group of public companies. The Company estimated the forfeiture rate at the time of grant and will revise it, if necessary, in subsequent periods if actual forfeitures differ from those estimates. The Company recognizes compensation costs only for those equity awards expected to vest. The risk-free rate for periods within the contractual life of the option is based on the U.S. Treasury yield in effect at the time of grant. The Company has never declared or paid dividends and has no plans to do so in the foreseeable future. The Company did not grant stock options in 2012.
	The following weighted-average assumptions were utilized in the calculation of the fair value of the stock options:
	Expected life		6.25 years
	Weighted average volatility		33	%
	Forfeiture rate		13	%
	Weighted average risk-free interest rate		1.31	%
	Expected dividend rate		-
	The fair value of stock options granted estimated on the date of grant using the Black-Scholes option valuation model was $307,000. The recognized compensation expense associated with these grants in 2013 was $76,000.
	A summary of the Company’s stock option activity and related information is as follows:
			2013							2012
			Common		Weighted			Weighted		Common		Weighted		Weighted
			Stock		Average			Average		Stock		Average		Average
					Exercise			Remaining				Exercise		Remaining
					Price			Contractual				Price		Contractual
								Life						Life
								(in years)						(in years)
	Outstanding at January 1		359,375		$	2.2		8.75		359,375		$	2.2	9.75
	Granted		206,390		$	4.91		9.01		-			-	-
	Exercised		-			-		-		-			-	-
	Forfeited/Expired/Exchanged		-			-		-		-			-	-
	Outstanding at December 31		565,765		$	3.19		8.21		359,375		$	2.2	8.75
	Exercisable at December 31		317,354		$	2.44		7.87		242,188		$	2.2	8.75
	A summary of the status of the Company’s non-vested stock options at December 31 and changes during the year is as follows:
			2013						2012
					Weighted						Weighted
					Average						Average
			Number of			Grant Date			Number of			Grant Date
			Options			Fair Value			Options			Fair Value
	Non-vested stock options at January 1		117,188		$	2.2			234,375		$	2.2
	Granted		206,390		$	4.91			-			-
	Vested		-75,167		$	3.21			-117,188		$	2.2
	Exercised		-			-			-			-
	Forfeited/Expired/Exchanged		-			-			-			-
	Non-vested stock options at December 31		248,411		$	4.15			117,188		$	2.2
	At December 31, 2013, there was $290,000 of total unrecognized compensation cost related to non-vested stock option-based compensation arrangements granted under the Equity Incentive Plan. That cost is expected to be recognized in future years as follows:
	2014		$	116,000
	2015			97,000
	2016			76,000
	2017			1,000
			$	290,000
	The recognized compensation cost is as follows:
			2013			2012			For the Period
									from Inception
									(January 23, 2008)
									to
									December 31, 2013
	Research and development		$	42,000		$	16,000		$	66,000
General and administrative			73,000			23,000			199,000
Effect on net loss		$	115,000		$	39,000		$	265,000
Effect on net loss per share		$	0.01		$	0.01		$	0.06
Stock Grants
In 2013 and 2012, the Company granted 30,000 and 20,799 shares, respectively, of common stock under the Equity Incentive Plan to its three independent directors in accordance with agreements for service on the board.  The fair value of the stock at the time of grant was $5.00 and $4.94 per share for a total value of $150,000 and $103,000 which the Company recognized in general and administrative expense in 2013 and 2012, respectively.
In 2011, the Company granted 125,000 shares of stock under the Equity Incentive Plan to a key employee which are subject to declining repurchase rights by the Company at $0.0001 per share should the employee terminate employment or upon other related circumstances prior to June 30, 2015. The fair value of the stock at the time of grant was $2.20 per share for a total value of $275,000. After the repurchase rights had expired on 62,500 shares, the Company terminated the remaining stock grant agreement in December 2012 and issued a new stock grant for 62,500 shares of which 2,500 shares were vested immediately. The new stock grant is subject to declining repurchase rights by the Company on 60,000 shares at $0.0001 per share should the employee terminate employment or upon other related circumstances prior to September 30, 2016.  The Company recognized general and administrative compensation expense of $31,000 and $96,000 in 2013 and 2012, respectively, and $202,000 for the period from inception (January 23, 2008) to December 31, 2013. The remaining cost is reflected as a contra-equity balance against additional paid in capital and is expected to be recognized in future years as follows:
2014		$	27,000
2015			26,000
2016			20,000
		$	73,000
Consultant Stock Plan
On May 2, 2013, the shareholders approved the 2013 Consultant Stock Plan (the Consultant Plan) which provides for the granting of shares of common stock to consultants who provide services related to capital raising, investor relations, and making a market in or promoting the Company’s securities. The Company’s officers, employees, and board members are not entitled to receive grants from the Consultant Plan. The Compensation Committee of the Board of Directors is authorized to administer the Consultant Plan and establish the grant terms. The number of shares reserved for issuance under the Consultant Plan on the date of adoption of May 2, 2013 totaled 75,000 shares. The Consultant Plan provides for quarterly increases in the available number of authorized shares equal to the lesser of 1% of any new shares issued by the Company during the quarter immediately prior to the adjustment date or such lesser amount as the Board of Directors shall determine.  The Company granted 11,250 shares from the Consultant Plan to a consultant for 2013 services. The fair value of the stock at the time of grant was $9.12 per share for a total value of $102,000 which the Company recognized in general and administrative expense in 2013. Activity under the Consultant Plan in 2013 is as follows:
Reserved but unissued shares under the Consultant Plan at May 2, 2013		75,000
Increases in the number of authorized shares under the Plan		287
Stock grants		-11,250
Stock grant forfeitures		-
Reserved but unissued shares under the Consultant Plan at December 31, 2013		64,037
Warrants
In conjunction with the IPO in 2012, the Company granted warrants to MDB to purchase 345,000 common stock shares at $5.00 per share exercisable from April 2013 to April 2017. The fair value of the warrants was estimated to be $128,000 on the date of the grant using the Black-Scholes option-pricing model. Expected volatility was determined through the average of a peer group of public companies. The risk-free rate for periods within the contractual life of the warrants is based on the U.S. Treasury yield in effect at the time of grant. The Company has never declared or paid dividends and has no plans to do so in the foreseeable future. The following weighted-average assumptions were utilized for the calculations:
Expected life (in years)		2.5
Weighted average volatility		27	%
Weighted average risk-free interest rate		0.33	%
Expected dividend rate		-
In 2013, a warrant to purchase 17,409 shares of common stock at $2.20 per share was exercised whereby the Company received $39,000 in proceeds. A summary of the Company’s warrant activity and related information is as follows:
		2013					2012
		Warrants		Weighted Average			Warrants		Weighted Average
				Exercise Price					Exercise Price
Outstanding at beginning of year		561,368		$	3.86		216,368		$	3.25
Granted		-			-		345,000		$	5
Exercised		-17,409		$	2.2		-			-
Forfeited/Expired		-			-		-			-
Outstanding at end of year		543,959		$	3.92		561,368		$	3.86
The following table summarizes the number of warrants, the weighted average exercise price, and weighted average life (in years) by price for both total outstanding warrants and total exercisable warrants at December 31, 2013:
			Total Outstanding Warrants
Exercise Price			Warrants		Weighted Average			Life
					Exercise Price			(in years)
$	1.8		80,000		$	1.8		7.13
$	2.2		118,959		$	2.2		2.36
$	5		345,000		$	5		3.32
			543,959		$	3.92

Retirement_Plan

Retirement Plan	12 Months Ended
	Dec. 31, 2013
Retirement Plan [Abstract]	'
Retirement Plan [Text Block]	'
	Note 7 – Retirement Plan
	In May 2012, the Company adopted a defined contribution retirement plan covering all of its employees.  Under the plan, the Company matches employee contributions up to 3% of each employee’s 2013 earnings and 2% of each employee’s 2012 earnings.  The Company’s matching contribution expense totaled $38,000, $24,000, and $62,000 in 2013, 2012, and for the period from inception (January 23, 2008) to December 31, 2013, respectively.

Related_Party_Transactions

Related Party Transactions	12 Months Ended
	Dec. 31, 2013
Related Party Transactions [Abstract]	'
Related Party Transactions Disclosure [Text Block]	'
	Note 8 – Related Party Transactions
	In 2013 and 2012 and for the period from inception (January 23, 2008) to December 31, 2013, the Company paid consulting fees of $103,000, $145,000 and $365,000, respectively, to the Alternative Energy Resource Alliance, a non-profit organization whose executive director is David Goodson.  In exchange, Mr. Goodson provided scientific consulting services to the Company.  Mr. Goodson is a director and co-founder of the Company and, through an irrevocable trust, a significant beneficial owner of the Company's common stock at December 31, 2013.
	MDB was paid $4,000 and $76,000 for patent work and related expenses in 2013 and 2012, respectively.  In 2012, MDB provided underwriting services for which it received fees of $1.2 million along with a warrant to purchase 345,000 shares of ClearSign’s common stock at $5.00 per share exercisable through April 2017 valued at $128,000. In 2011, MDB provided placement agent services for which it received fees of $300,000, which it elected to receive in the form of 136,364 common stock shares valued at $2.20 per share, along with a warrant to purchase 136,368 shares of ClearSign’s common stock at $2.20 per share exercisable through May 2016 valued at $64,000. In addition, MDB provided consulting services to the Company in 2011 where it earned a fee of $1 million which MDB elected to receive in the form of 454,547 common stock shares valued at $2.20 per share.  For the period from inception (January 23, 2008) to December 31, 2013, MDB received a total of $1,280,000, 590,911 shares of common stock valued at $1,300,000, and warrants to purchase 481,368 shares of ClearSign’s common stock at a weighted average price of $4.21 per share exercisable through April 2017 and valued at $192,000.  MDB and its chief executive officer constitute a significant beneficial owner of the Company's common stock at December 31, 2013.

Commitments_and_Contingencies

Commitments and Contingencies	12 Months Ended
	Dec. 31, 2013
Commitments and Contingencies Disclosure [Abstract]	'
Commitments and Contingencies Disclosure [Text Block]	'
	Note 9 – Commitments and Contingencies
	The Company has a triple net lease for office and laboratory space for the period November 2011 to February 2017. Under the terms of the lease, the Company paid no rent for the period November 2011 to February 2012. Rent payments commenced in March 2012 and escalate annually by 3%. The Company records monthly rent expense equal to the total of the payments over the lease term divided by the number of months of the lease term. Therefore, rent expense of $17,000 was accrued in 2012. In 2013, the deferred rent was reduced by $4,000. Under the terms of the lease, the Company will also pay monthly triple net operating costs which currently approximate $2,000 per month. Minimum future payments under this lease at December 31, 2013 are as follows:
	2014	$	120,000
	2015		137,000
	2016		141,000
	2017		24,000
		$	422,000
	For the years ended December 31, 2013 and 2012, and for the period from inception (January 23, 2008) to December 31, 2013, rent expense amounted to $135,000, $137,000, and $428,000, respectively.
	The Company and its Chief Executive Officer, Richard F. Rutkowski, are parties to an employment agreement (the Agreement) which terminates on January 1, 2017, unless earlier terminated. Compensation under the Agreement includes an annual salary of $355,000 and $350,000 in 2013 and 2012, respectively, with annual cost-of-living adjustments, annual cash and equity bonuses based on performance standards established by the Compensation Committee of the Board of Directors, medical and dental benefits for Mr. Rutkowski and his family, disability insurance, and term life insurance for the benefit of his dependents. The Agreement may be terminated by the Company without cause under certain circumstances, as defined in the Agreement whereby a severance payment would be due in the amount of compensation that would have been due had employment not been terminated or one year of the current annual compensation, whichever is greater.
	The Company has agreements with its three independent directors to compensate them annually after the Company’s common stock commenced trading publicly. The obligation totals $300,000 per year of which $150,000 is to be paid with the Company’s common stock at fair value. Directors are elected for annual terms which expire in May 2014.
	The Company’s former legal advisors, Perkins Coie LLP, contacted management in March 2012 that they believe TWB Investment Partnership II, L.P., a party related to Perkins Coie LLP, has the right to acquire 25,250 shares of the Company’s common stock at $0.02 per share pursuant to an engagement letter dated December 4, 2007. The claim was denied since, among other defenses, management believes it entered into a full settlement of all amounts owed to Perkins Coie LLP in November 2011. There has been no further communication with Perkins Coie LLP regarding the matter since March 2012.

Subsequent_Events

Subsequent Events	12 Months Ended
	Dec. 31, 2013
Subsequent Events [Abstract]	'
Subsequent Events [Text Block]	'
	Note 10 – Subsequent Events
	In March 2014, the Company completed a registered direct  offering of common stock whereby  812,500 shares were issued at $8.00 per share. Gross proceeds from the offering totaled $6.5 million and net cash proceeds approximated $5.7 million. Expenses of the offering approximated $0.8 million, including  placement agent fees of $0.5 million along with a warrant to purchase  20,313 shares of ClearSign’s common stock at $10.00 per share exercisable until March 2019,  placement agent legal fees of $75,000,  and other costs of $175,000.
	In February 2014, the Company granted 14,625 shares of common stock under the Equity Incentive Plan to its three independent directors in accordance with board agreements for service in 2014.  The Company also granted 7,000 shares of common stock under the Consultant Stock Plan to a consultant for service in 2014.   The fair value of the stock at the time of grant was $10.26 per share for a total value of $222,000 which the Company will recognize in general and administrative expense on a pro-rated quarterly basis in 2014.
	In February 2014, the Company granted 122,880 stock options under the Equity Incentive Plan to certain employees. The stock options have an exercise price of $9.90 per share, the grant date fair value, and a contractual life of 10 years. The fair value of stock options granted in February 2014 estimated on the date of grant using the Black-Scholes option valuation model was $369,000.
	After taking into effect the February 2014 stock option grant, the total unrecognized compensation cost related to non-vested stock option-based compensation arrangements granted under the Equity Incentive Plan that is expected to be recognized in future years as follows:
	2014	$	208,000
	2015		189,000
	2016		169,000
	2017		93,000
		$	659,000
	Activity under the Equity Incentive Plan through February 2014 is as follows:
	Reserved but unissued shares under the Equity Incentive Plan, January 1, 2014	249,736
	Increases in the number of authorized shares under the Equity Incentive Plan	1,818
	Grants of stock options	-122,880
	Stock grants	-14,625
	Reserved but unissued shares under the Equity Incentive Plan, February 28, 2014	114,049

Summary_of_Significant_Account1

Summary of Significant Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2013
Accounting Policies [Abstract]	'
Development Stage Enterprise Policy [Policy Text Block]	'
	Development Stage Enterprise
	The Company is a development stage company as defined in Financial Accounting Standards Board (FASB) Accounting Standards Codification (ASC) 915, Development Stage Entities. The Company is devoting substantially all of its present efforts to design and develop new technologies in combustion systems and its planned principal operations have not yet commenced. The Company has not generated any significant revenues from operations and has no assurance of any future revenues. All losses accumulated since January 23, 2008 have been considered as part of the Company's development stage activities.
Use Of Estimates, Policy [Policy Text Block]	'
	Use of Estimates
	The preparation of financial statements in conformity with accounting principles generally accepted in the United States (US GAAP) requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
Revenue Recognition, Policy [Policy Text Block]	'
	Revenue Recognition
	The Company recognizes revenue on co-development agreements using the percentage of completion method. Under this method, the completion percentage is determined by dividing costs incurred to date by total estimated project costs. Since these projects will require technological development to complete, which by its nature is difficult to predict, the actual cost required to complete contracted work may vary from estimates. Estimated project costs are revised regularly which can alter the reported level of project profitability. Any estimated project losses are recognized in the current reporting period. Customer billings are recorded when cash receipts are probable and in accordance with the underlying co-development contract. If billings exceed recognized revenue, the difference is recorded as a current liability, while any recognized revenues exceeding billings are recorded as a current asset. Recognized revenues are subject to revisions as the contract progresses to completion and actual revenue and cost become certain. Revisions in revenue estimates are reflected in the period in which the facts that give rise to the revision become known.
Cost of Sales, Policy [Policy Text Block]	'
	Cost of Revenue
	Cost of co-development revenue includes both direct and allocated indirect costs of completing the scope of work of co-development agreements. Direct costs include labor, materials and other costs incurred directly in fulfilling co-development agreements. Indirect costs include labor, rent, depreciation and other costs associated with operating the Company. Due to the nature of the work involved, the cost of co-development projects may fluctuate substantially from period to period.
Cash and Cash Equivalents, Policy [Policy Text Block]	'
	Cash and Cash Equivalents
	Highly liquid investments purchased with an original maturity of three months or less are considered cash equivalents. Cash is maintained with a commercial bank where accounts are generally guaranteed by the Federal Deposit Insurance Corporation up to $250,000. The Company’s deposits exceed this limit. The Company has not experienced losses in such accounts and believes it is not exposed to any significant credit risk on cash and cash equivalents.
Fixed Assets Policy [Policy Text Block]	'
	Fixed Assets
	Fixed assets are recorded at cost.  Depreciation is computed using the straight-line method over the estimated lives of the respective assets. Leasehold improvements are depreciated over the life of the lease or their useful life, whichever is shorter. All other fixed assets are depreciated over three to four years. Maintenance and repairs are expensed as incurred.
Patents and Trademarks Policy [Policy Text Block]	'
	Patents and Trademarks
	Patents and trademarks are recorded at cost. Amortization is computed using the straight-line method over the estimated useful lives of the assets once they are awarded, which has not yet occurred.
Impairment Of Long Lived Asset Policy [Policy Text Block]	'
	Impairment of Long-Lived Assets
	The Company tests long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable through the estimated undiscounted cash flows expected to result from the use and eventual disposition of the assets. In that event, a loss is recognized based on the amount by which the carrying amount exceeds the fair value of the long-lived assets. Loss on long-lived assets to be disposed of is determined in a similar manner, except that fair values are reduced for the cost of disposal. During 2013, the Company recorded an impairment loss of $4,000 from abandonment of a capitalized patent. As of December 31, 2012, the Company determined that there was no impairment.
Fair Value Of Financial Instruments, Policy [Policy Text Block]	'
	Fair Value of Financial Instruments
	Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Assets and liabilities measured at fair value are categorized based on whether or not the inputs are observable in the market and the degree that the inputs are observable. The categorization of financial assets and liabilities within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement.
	The Company's financial instruments primarily consist of cash and cash equivalents, accounts payable and accrued expenses. As of the balance sheet dates, the estimated fair values of the financial instruments were not materially different from their carrying values as presented on the balance sheets. This is primarily attributed to the short maturities of these instruments. The Company did not identify any other non-recurring assets and liabilities that are required to be presented in the balance sheets at fair value.
Research and Development Expense, Policy [Policy Text Block]	'
	Research and Development
	The cost of research and development is expensed as incurred. Research and development costs consist of salaries, benefits, share based compensation, consulting fees, rent, utilities, depreciation, and consumables.
Deferred Rent Policy [Policy Text Block]	'
	Deferred Rent
	Operating lease agreements which contain provisions for future rent increases or periods in which rent payments are reduced or abated are recorded in monthly rent expense in the amount of the total payments over the lease term divided by the number of months of the lease term. The difference between rent expense recorded and the amount paid is credited or charged to deferred rent which is reflected on the accompanying balance sheet.
Income Tax, Policy [Policy Text Block]	'
	Income Taxes
	The Company accounts for income taxes using an asset and liability approach which allows for the recognition and measurement of deferred tax assets based upon the likelihood of realization of tax benefits in future years. Under the asset and liability approach, deferred taxes are provided for the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. A valuation allowance is provided for deferred tax assets if it is more likely than not these items will either expire before the Company is able to realize their benefits, or that future deductibility is uncertain.
	Tax benefits from an uncertain tax position are recognized only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities based on the technical merits of the position. The tax benefits recognized in the financial statements from such a position are measured based on the largest benefit that has a greater than 50 percent likelihood of being realized upon ultimate resolution.
Share-Based Compensation, Option and Incentive Plans Policy [Policy Text Block]	'
	Stock-Based Compensation
	The costs of all employee stock options, as well as other equity-based compensation arrangements, are reflected in the financial statements based on the estimated fair value of the awards on the grant date. That cost is recognized over the period during which an employee is required to provide service in exchange for the award. Stock compensation for stock granted to non-employees is determined as the fair value of the consideration received or the fair value of equity instruments issued, whichever is more reliably measured.
Earnings Per Share, Policy [Policy Text Block]	'
	Net Loss per Common Share
	Basic loss per share is computed by dividing loss available to common stockholders by the weighted-average number of common shares outstanding. Diluted loss per share is computed similar to basic loss per share except that the denominator is increased to include additional common shares available upon exercise of stock options and warrants using the treasury stock method, except for periods for which no common share equivalents are included because their effect would be anti-dilutive. Potentially dilutive shares outstanding amounted to 1,109,724 and 920,743 at December 31, 2013 and 2012, respectively.
New Accounting Pronouncements, Policy [Policy Text Block]	'
	Recently Issued Accounting Pronouncements
	Management does not believe that any recently issued, but not yet effective standards, if adopted, will have a material effect on the financial statements.
Growing Company [Policy Text Block]	'
	Emerging Growth Company
	The Company is an emerging growth company as defined under the Jumpstart Our Business Startups Act of 2012 (JOBS Act).  An emerging growth company may delay the adoption of certain accounting standards until those standards would otherwise apply to private companies.  The Company will remain an emerging growth company until December 31, 2017, although it will lose that status sooner if its revenues exceed $1 billion, if it issues more than $1 billion in non-convertible debt in a three year period, or if the market value of its common stock that is held by non-affiliates exceeds $700 million as of any June 30. At June 30, 2013, the market value of the Company’s common stock that is held by non-affiliates totaled $60 million.

Fixed_Assets_Tables

Fixed Assets (Tables)	12 Months Ended
	Dec. 31, 2013
Property, Plant and Equipment [Abstract]	'
Property, Plant and Equipment [Table Text Block]	'
	Fixed assets are summarized as follows:
		December 31,
		2013		2012
	Machinery and equipment	$	633,000	$	444,000
	Office furniture and equipment		95,000		71,000
	Leasehold improvements		62,000		29,000
	Accumulated depreciation		-366,000		-157,000
			424,000		387,000
	Construction in progress		3,000		13,000
		$	427,000	$	400,000

Income_Taxes_Tables

Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2013
Income Tax Disclosure [Abstract]	'
Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]	'
	A reconciliation of the expected tax computed at the statutory federal income tax rate to the provision for income taxes is as follows:
		2013		2012
	Expected tax benefit at 34%	$	-1,797,000	$	-1,424,000
	Change in valuation allowance		1,720,000		1,675,000
	Other		77,000		-251,000
	Provision for income taxes	$	-	$	-
Schedule of Deferred Tax Assets and Liabilities [Table Text Block]	'
	A 100% valuation allowance has been established against the deferred tax assets as the utilization of the loss carry forward cannot reasonably be assured. Significant components of the deferred tax assets (liabilities), computed at the statutory federal tax rate of 34%, are approximately as follows:
		2013		2012
	Net operating loss carry forwards	$	4,800,000	$	3,020,000
	Accrued liabilities		-25,000		-20,000
	Stock compensation		-65,000		-15,000
	Depreciation		75,000		80,000
	Prepaid expenses		20,000		20,000
	Deferred rent		-10,000		-10,000
	Deferred tax assets, net		4,795,000		3,075,000
	Valuation allowance		-4,795,000		-3,075,000
	Net deferred tax asset	$	-	$	-

Stockholders_Equity_Tables

Stockholders' Equity (Tables)	12 Months Ended
	Dec. 31, 2013
Schedule of Share-based Compensation, Activity [Table Text Block]	'
	A summary of the status of the Company’s non-vested stock options at December 31 and changes during the year is as follows:
			2013						2012
					Weighted						Weighted
					Average						Average
			Number of			Grant Date			Number of			Grant Date
			Options			Fair Value			Options			Fair Value
	Non-vested stock options at January 1		117,188		$	2.2			234,375		$	2.2
	Granted		206,390		$	4.91			-			-
	Vested		-75,167		$	3.21			-117,188		$	2.2
	Exercised		-			-			-			-
	Forfeited/Expired/Exchanged		-			-			-			-
	Non-vested stock options at December 31		248,411		$	4.15			117,188		$	2.2
Schedule Of Recognized Compensation Cost [Table Text Block]	'
	The recognized compensation cost is as follows:
			2013			2012			For the Period
									from Inception
									(January 23, 2008)
									to
									December 31, 2013
	Research and development		$	42,000		$	16,000		$	66,000
	General and administrative			73,000			23,000			199,000
	Effect on net loss		$	115,000		$	39,000		$	265,000
	Effect on net loss per share		$	0.01		$	0.01		$	0.06
Schedule Of Expected Recognition Of General And Administrative Expense [Table Text Block]	'
	The remaining cost is reflected as a contra-equity balance against additional paid in capital and is expected to be recognized in future years as follows:
	2014		$	27,000
	2015			26,000
	2016			20,000
			$	73,000
Schedule Of Share Based Payment Award Warrants Valuation Assumptions [Table Text Block]	'
	The following weighted-average assumptions were utilized for the calculations:
	Expected life (in years)		2.5
	Weighted average volatility		27	%
	Weighted average risk-free interest rate		0.33	%
	Expected dividend rate		-
Schedule Of Share Based Compensation Warrants Activity [Table Text Block]	'
	The following table summarizes the number of warrants, the weighted average exercise price, and weighted average life (in years) by price for both total outstanding warrants and total exercisable warrants at December 31, 2013:
				Total Outstanding Warrants
	Exercise Price			Warrants		Weighted Average			Life
						Exercise Price			(in years)
	$	1.8		80,000		$	1.8		7.13
	$	2.2		118,959		$	2.2		2.36
	$	5		345,000		$	5		3.32
				543,959		$	3.92
Employee Stock Option [Member]	'
Schedule Of Share Based Payment Award Warrants Valuation Assumptions [Table Text Block]	'
	The following weighted-average assumptions were utilized in the calculation of the fair value of the stock options:
	Expected life		6.25 years
	Weighted average volatility		33	%
	Forfeiture rate		13	%
	Weighted average risk-free interest rate		1.31	%
	Expected dividend rate		-
Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]	'
	A summary of the Company’s stock option activity and related information is as follows:
			2013							2012
			Common		Weighted			Weighted		Common		Weighted		Weighted
			Stock		Average			Average		Stock		Average		Average
					Exercise			Remaining				Exercise		Remaining
					Price			Contractual				Price		Contractual
								Life						Life
								(in years)						(in years)
	Outstanding at January 1		359,375		$	2.2		8.75		359,375		$	2.2	9.75
	Granted		206,390		$	4.91		9.01		-			-	-
	Exercised		-			-		-		-			-	-
	Forfeited/Expired/Exchanged		-			-		-		-			-	-
	Outstanding at December 31		565,765		$	3.19		8.21		359,375		$	2.2	8.75
	Exercisable at December 31		317,354		$	2.44		7.87		242,188		$	2.2	8.75
Schedule Of Employee Service Share Based Compensation Unrecognized Period Costs [Table Text Block]	'
	At December 31, 2013, there was $290,000 of total unrecognized compensation cost related to non-vested stock option-based compensation arrangements granted under the Equity Incentive Plan. That cost is expected to be recognized in future years as follows:
	2014		$	116,000
	2015			97,000
	2016			76,000
	2017			1,000
			$	290,000
Warrant [Member]	'
Schedule Of Share Based Compensation Warrants Activity [Table Text Block]	'
	A summary of the Company’s warrant activity and related information is as follows:
			2013					2012
			Warrants		Weighted Average			Warrants		Weighted Average
					Exercise Price					Exercise Price
	Outstanding at beginning of year		561,368		$	3.86		216,368		$	3.25
	Granted		-			-		345,000		$	5
	Exercised		-17,409		$	2.2		-			-
	Forfeited/Expired		-			-		-			-
	Outstanding at end of year		543,959		$	3.92		561,368		$	3.86
Equity Incentive Plan [Member]	'
Schedule of Share-based Compensation, Activity [Table Text Block]	'
	Activity under the Equity Incentive Plan is as follows:
			2013		2012
	Reserved but unissued shares under the Equity Incentive Plan, beginning of year		480,260		140,625
	Increases in the number of authorized shares under the Equity Incentive Plan		5,866		360,434
	Grants of stock options		-206,390		-
	Stock option forfeitures		-		-
	Stock grants		-30,000		-83,299
	Stock grant forfeitures		-		62,500
	Reserved but unissued shares under the Equity Incentive Plan, end of year		249,736		480,260
Consultant Plan [Member]	'
Schedule of Share-based Compensation, Activity [Table Text Block]	'
	Activity under the Consultant Plan in 2013 is as follows:
	Reserved but unissued shares under the Consultant Plan at May 2, 2013		75,000
	Increases in the number of authorized shares under the Plan		287
	Stock grants		-11,250
	Stock grant forfeitures		-
	Reserved but unissued shares under the Consultant Plan at December 31, 2013		64,037

Commitments_and_Contingencies_

Commitments and Contingencies (Tables)	12 Months Ended
	Dec. 31, 2013
Commitments and Contingencies Disclosure [Abstract]	'
Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block]	'
	Minimum future payments under this lease at December 31, 2013 are as follows:
	2014	$	120,000
	2015		137,000
	2016		141,000
	2017		24,000
		$	422,000

Subsequent_Events_Tables

Subsequent Events (Tables)	12 Months Ended
	Dec. 31, 2013
Schedule of Share-based Compensation, Activity [Table Text Block]	'
	A summary of the status of the Company’s non-vested stock options at December 31 and changes during the year is as follows:
		2013				2012
				Weighted			Weighted
				Average			Average
		Number of			Grant Date	Number of		Grant Date
		Options			Fair Value	Options		Fair Value
	Non-vested stock options at January 1	117,188		$	2.2	234,375	$	2.2
	Granted	206,390		$	4.91	-		-
	Vested	-75,167		$	3.21	-117,188	$	2.2
	Exercised	-			-	-		-
	Forfeited/Expired/Exchanged	-			-	-		-
	Non-vested stock options at December 31	248,411		$	4.15	117,188	$	2.2
Subsequent Event [Member]	'
Schedule of Unrecognized Compensation Cost, Nonvested Awards [Table Text Block]	'
	After taking into effect the February 2014 stock option grant, the total unrecognized compensation cost related to non-vested stock option-based compensation arrangements granted under the Equity Incentive Plan that is expected to be recognized in future years as follows:
	2014	$	208,000
	2015		189,000
	2016		169,000
	2017		93,000
		$	659,000
Schedule of Share-based Compensation, Activity [Table Text Block]	'
	Activity under the Equity Incentive Plan through February 2014 is as follows:
	Reserved but unissued shares under the Equity Incentive Plan, January 1, 2014	249,736
	Increases in the number of authorized shares under the Equity Incentive Plan	1,818
	Grants of stock options	-122,880
	Stock grants	-14,625
	Reserved but unissued shares under the Equity Incentive Plan, February 28, 2014	114,049

Organization_and_Description_o1

Organization and Description of Business (Details Textual) (USD $)	12 Months Ended		47 Months Ended	71 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2013
Organization and Description of Business [Line Items]	'	'	'	'
Net Income (Loss) Attributable To Parent	($5,285,000)	($4,189,000)	($4,490,000)	($13,964,000)

Summary_of_Significant_Account2

Summary of Significant Accounting Policies (Details Textual) (USD $)	12 Months Ended		71 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013	Jun. 30, 2013
Variable Interest Entity [Line Items]	'	'	'	'
Cash, FDIC Insured Amount	$250,000	'	$250,000	'
Exploration Abandonment and Impairment Expense	4,000	0	4,000	'
Weighted Average Number of Shares Outstanding, Diluted	1,109,724	920,743	'	'
Emerging Growth Company Minimum Revenue	1,000,000,000	'	'	'
Emerging Growth Company Non Convertible Debt	1,000,000,000	'	1,000,000,000	'
Emerging Growth Company Minimum Non-Affiliate Market Value Of Common Stock	'	'	'	700,000,000
Tax Benefits Recognized Description	'The tax benefits recognized in the financial statements from such a position are measured based on the largest benefit that has a greater than 50 percent likelihood of being realized upon ultimate resolution.	'	'	'
Emerging Growth Company Non-Affiliate Market Value Of Common Stock	'	'	'	$60,000,000

Fixed_Assets_Details

Fixed Assets (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012
Property, Plant and Equipment [Line Items]	'	'
Machinery and equipment	$633,000	$444,000
Office furniture and equipment	95,000	71,000
Leasehold improvements	62,000	29,000
Accumulated depreciation	-366,000	-157,000
Property Plant and Equipment Gross Excluding Construction In Progress	424,000	387,000
Construction in progress	3,000	13,000
Property, Plant and Equipment, Net, Total	$427,000	$400,000

Promissory_Notes_Details_Textu

Promissory Notes (Details Textual) (USD $)	0 Months Ended	12 Months Ended
	Apr. 30, 2012	Dec. 31, 2011
Short-term Debt [Line Items]	'	'
Short-term Debt	$98,000	$48,000
Debt Instrument, Interest Rate, Stated Percentage	3.39%	8.00%
Debt Instrument, Periodic Payment	$11,000	$4,000

Income_Taxes_Details

Income Taxes (Details) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Income Tax Contingency [Line Items]	'	'
Expected tax benefit at 34%	($1,797,000)	($1,424,000)
Change in valuation allowance	1,720,000	1,675,000
Other	77,000	-251,000
Provision for income taxes	$0	$0

Income_Taxes_Details_1

Income Taxes (Details 1) (USD $)	Dec. 31, 2013	Dec. 31, 2012
Income Tax Contingency [Line Items]	'	'
Net operating loss carry forwards	$4,800,000	$3,020,000
Accrued liabilities	-25,000	-20,000
Stock compensation	-65,000	-15,000
Depreciation	75,000	80,000
Prepaid expenses	20,000	20,000
Deferred rent	-10,000	-10,000
Deferred tax assets, net	4,795,000	3,075,000
Valuation allowance	-4,795,000	-3,075,000
Net deferred tax asset	$0	$0

Income_Taxes_Details_Textual

Income Taxes (Details Textual) (USD $)	12 Months Ended
	Dec. 31, 2013
Income Tax Contingency [Line Items]	'
Net Operating Losses For Tax Purposes	$14,100,000
Limitation In Carry Forward Percentage Of Net Operating Loss	50.00%
Percentage Of Valuation Allowance Against Deferred Tax Assets	100.00%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent	34.00%
Operating Loss Carryforward Expiration Date	'The net operating loss carry forward may be used to reduce taxable income through the years 2028 to 2033.

Stockholders_Equity_Details

Stockholders' Equity (Details) (Equity Incentive Plan [Member])	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Equity Incentive Plan [Member]	'	'
Class of Stock [Line Items]	'	'
Reserved but unissued shares under the Equity Incentive Plan, Opening	480,260	140,625
Increases in the number of authorized shares under the Equity Incentive Plan	5,866	360,434
Grants of stock options	-206,390	0
Stock option forfeitures	0	0
Stock grants	-30,000	-83,299
Stock grant forfeitures	0	62,500
Reserved but unissued shares under the Equity Incentive Plan, Ending	249,736	480,260

Stockholders_Equity_Details_1

Stockholders' Equity (Details 1)	12 Months Ended
	Dec. 31, 2013
Class of Stock [Line Items]	'
Expected life	'6 years 3 months
Weighted average volatility	33.00%
Forfeiture rate	13.00%
Weighted average risk-free interest rate	1.31%
Expected dividend rate	0.00%

Stockholders_Equity_Details_2

Stockholders' Equity (Details 2) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Class of Stock [Line Items]	'	'	'
Exercisable - Weighted Average Exercise Price	$4.88	'	'
Employee Stock Option [Member]	'	'	'
Class of Stock [Line Items]	'	'	'
Reserved but unissued shares under the Equity Incentive Plan, Opening	359,375	359,375	'
Granted - Common Stock	206,390	0	'
Exercised - Common Stock	0	0	'
Forfeited/Expired/Exchanged - Common Stock	0	0	'
Reserved but unissued shares under the Equity Incentive Plan, Ending	565,765	359,375	359,375
Exercisable - Common Stock	317,354	242,188	'
Outstanding - Weighted Average Exercise Price	$2.20	$2.20	'
Granted - Weighted Average Exercise Price	$4.91	$0	'
Exercised - Weighted Average Exercise Price	$0	$0	'
Forfeited/Expired/Exchanged - Weighted Average Exercise Price	$0	$0	'
Outstanding - Weighted Average Exercise Price	$3.19	$2.20	$2.20
Exercisable - Weighted Average Exercise Price	$2.44	$2.20	'
Outstanding - Weighted Average Remaining Contractutal Life (in years)	'	'8 years 9 months	'9 years 9 months
Granted - Weighted Average Remaining Contractual Life (in years)	'9 years 4 days	'0 years	'
Exercised - Weighted Average Remaining Contractual Life (in years)	'0 years	'0 years	'
Forfeited/Expired/Exchanged - Weighted Average Remaining Contractual Life (in years)	'0 years	'0 years	'
Outstanding - Weighted Average Remaining Contractutal Life (in years)	'8 years 2 months 16 days	'	'
Exercisable - Weighted Average Remaining Contractual Life (in years)	'7 years 10 months 13 days	'8 years 9 months	'

Stockholders_Equity_Details_3

Stockholders' Equity (Details 3) (Employee Stock Option [Member], USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Employee Stock Option [Member]	'	'
Class of Stock [Line Items]	'	'
Non-vested options - Number of Options	117,188	234,375
Granted - Number of Options	206,390	0
Vested - Number of Options	-75,167	-117,188
Exercised - Number of Options	0	0
Forfeited/Expired/Exchanged - Number of Options	0	0
Non-vested options - Number of Options	248,411	117,188
Non-vested options - Weighted Average Grant Date Fair Value	$2.20	$2.20
Granted - Weighted Average Grant Date Fair Value	$4.91	$0
Vested - Weighted Average Grant Date Fair Value	$3.21	$2.20
Exercised - Weighted Average Grant Date Fair Value	$0	$0
Forfeited/Expired/Exchanged - Weighted Average Grant Date Fair Value	$0	$0
Non-vested options - Weighted Average Grant Date Fair Value	$4.15	$2.20

Stockholders_Equity_Details_4

Stockholders' Equity (Details 4) (USD $)	Dec. 31, 2013
Class of Stock [Line Items]	'
Employee Service Share-Based Compensation, Nonvested Awards, Total Compensation Cost Not Yet Recognized	$290,000
Year 2014 [Member]	'
Class of Stock [Line Items]	'
Employee Service Share-Based Compensation, Nonvested Awards, Total Compensation Cost Not Yet Recognized	116,000
Year 2015 [Member]	'
Class of Stock [Line Items]	'
Employee Service Share-Based Compensation, Nonvested Awards, Total Compensation Cost Not Yet Recognized	97,000
Year 2016 [Member]	'
Class of Stock [Line Items]	'
Employee Service Share-Based Compensation, Nonvested Awards, Total Compensation Cost Not Yet Recognized	76,000
Year 2017 [Member]	'
Class of Stock [Line Items]	'
Employee Service Share-Based Compensation, Nonvested Awards, Total Compensation Cost Not Yet Recognized	$1,000

Stockholders_Equity_Details_5

Stockholders' Equity (Details 5) (USD $)	12 Months Ended		71 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013
Class of Stock [Line Items]	'	'	'
Share Based Compensation Effect On Net Loss	$115,000	$39,000	$265,000
Share Based Compensation Effect Of Net Loss Per Share	$0.01	$0.01	$0.06
Research and Development Expense [Member]	'	'	'
Class of Stock [Line Items]	'	'	'
Share Based Compensation Effect On Net Loss	42,000	16,000	66,000
General and Administrative Expense [Member]	'	'	'
Class of Stock [Line Items]	'	'	'
Share Based Compensation Effect On Net Loss	$73,000	$23,000	$199,000

Stockholders_Equity_Details_6

Stockholders' Equity (Details 6) (USD $)	12 Months Ended
	Dec. 31, 2013
Class of Stock [Line Items]	'
Other General and Administrative Expense	$73,000
Year 2014 [Member]	'
Class of Stock [Line Items]	'
Other General and Administrative Expense	27,000
Year 2015 [Member]	'
Class of Stock [Line Items]	'
Other General and Administrative Expense	26,000
Year 2016 [Member]	'
Class of Stock [Line Items]	'
Other General and Administrative Expense	$20,000

Stockholders_Equity_Details_7

Stockholders' Equity (Details 7) (Consultant Plan [Member])	12 Months Ended
	Dec. 31, 2013
Consultant Plan [Member]	'
Class of Stock [Line Items]	'
Reserved but unissued shares under the Equity Incentive Plan, Opening	75,000
Increases in the number of authorized shares under the Plan	287
Stock grants	-11,250
Stock grant forfeitures	0
Reserved but unissued shares under the Equity Incentive Plan, Ending	64,037

Stockholders_Equity_Details_8

Stockholders' Equity (Details 8)	12 Months Ended
	Dec. 31, 2013
Class of Stock [Line Items]	'
Expected life (in years)	'6 years 3 months
Weighted average volatility	33.00%
Weighted average risk-free interest rate	1.31%
Expected dividend rate	0.00%
Warrant [Member]	'
Class of Stock [Line Items]	'
Expected life (in years)	'2 years 6 months
Weighted average volatility	27.00%
Weighted average risk-free interest rate	0.33%
Expected dividend rate	0.00%

Stockholders_Equity_Details_9

Stockholders' Equity (Details 9) (Warrant [Member], USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Warrant [Member]	'	'
Class of Stock [Line Items]	'	'
Outstanding - Warrants	561,368	216,368
Granted - Warrants	0	345,000
Exercised - Warrants	-17,409	0
Forfeited/Expired - Warrants	0	0
Outstanding - Warrants	543,959	561,368
Outstanding - Weighted Average Exercise Price	$3.86	$3.25
Granted - Weighted Average Exercise Price	$0	$5
Exercised - Weighted Average Exercise Price	$2.20	$0
Forfeited/Expired - Weighted Average Exercise Price	$0	$0
Outstanding - Weighted Average Exercise Price	$3.92	$3.86

Stockholders_Equity_Details_10

Stockholders' Equity (Details 10) (USD $)	12 Months Ended
	Dec. 31, 2013
Class of Stock [Line Items]	'
Warrants Outstanding	543,959
Warrants Outstanding Weighted Average Exercise Price	$3.92
Warrant 1 [Member]	'
Class of Stock [Line Items]	'
Warrants Exercise Price	$1.80
Warrants Outstanding	80,000
Warrants Outstanding Weighted Average Exercise Price	$1.80
Warrants Outstanding Remaining Life (in Years)	'7 years 1 month 17 days
Warrant 2 [Member]	'
Class of Stock [Line Items]	'
Warrants Exercise Price	$2.20
Warrants Outstanding	118,959
Warrants Outstanding Weighted Average Exercise Price	$2.20
Warrants Outstanding Remaining Life (in Years)	'2 years 4 months 10 days
Warrant 3 [Member]	'
Class of Stock [Line Items]	'
Warrants Exercise Price	$5
Warrants Outstanding	345,000
Warrants Outstanding Weighted Average Exercise Price	$5
Warrants Outstanding Remaining Life (in Years)	'3 years 3 months 25 days

Stockholders_Equity_Details_Te

Stockholders' Equity (Details Textual) (USD $)	2 Months Ended	12 Months Ended			47 Months Ended	71 Months Ended
	31-May-12	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2011	Dec. 31, 2013
Class of Stock [Line Items]	'	'	'	'	'	'
Par value of shares issued in initial public offering	'	$4	$4	'	'	'
Stock Issued During Period, Value, New Issues	'	$13,800,000	$13,800,000	'	'	'
Net proceeds from Issuance of Common Stock	'	11,200,000	'	'	'	'
Underwriter Fees	'	1,200,000	1,200,000	300,000	'	'
Warrants Authorized For Issuance To Acquire Common Stock Shares Number	345,000	'	345,000	136,364	'	'
Exercise Price Of Warrants	$5	$5	$5	$2.20	'	'
Warrants Authorized For Issuance To Acquire Common Stock Value	128,000	128,000	128,000	'	'	'
Stock Issued During Period, Value, Issued for Noncash Considerations	110,000	'	'	125,000	'	'
Common Stock, Shares Authorized	'	62,500,000	'	'	'	62,500,000
Issuance costs of initial public offering	'	2,700,000	'	'	'	'
Preferred Stock, Shares Authorized	'	2,000,000	'	'	'	2,000,000
Share Based Compensation Arrangement By Share Based Payment Award Purchase Price Share Minimum	'	85.00%	'	'	'	'
Common Stock, Capital Shares Reserved for Future Issuance	'	991,300	'	'	'	991,300
Increase Decrease Of Share Based Compensation Arrangement By Share Based Payment Award Percentage	'	10.00%	'	'	'	'
Declining Repurchase Rights Per Share	'	'	'	$0.00	$0.00	'
Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized	'	290,000	'	'	'	290,000
Declining Repurchase Rights Value	'	'	'	0.0001	0.0001	'
Stock Issued During Period, Value, Exercise Of Warrant	'	39,000	'	'	'	'
Stock Issued During Period Par Value New Issues Three	'	'	'	$2.20	$2.20	'
Share Based Compensation Arrangement By Share Based Payment Award Grant Date Fair Value	'	'	'	275,000	'	'
Excess Stock, Shares Authorized	'	'	62,500	62,500	62,500	'
Share Based Compensation Arrangement By Share Based Payment Award Stock Grants Vested	'	'	'	2,500	'	'
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Subject To Repurchase Rights Decline	'	'	'	60,000	'	'
General And Administrative Expense Related To Stock Grant	'	31,000	96,000	'	'	202,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price	'	$4.88	'	'	'	$4.88
Stock Issued During Period Shares For Services Seven	'	30,000	'	'	'	'
Stock Issued During Period Shares For Services Six	'	'	20,799	'	'	'
Common Stock For Services Per Share Issue Seven	'	$9.12	'	'	'	'
Common Stock For Services Per Share Issue Six	'	$5	$4.94	'	'	'
Stock Issued During Period Value For Services Seven	'	150,000	'	'	'	'
Stock Issued During Period Value For Services Six	'	'	103,000	'	'	'
Stock Issued During Period, Value, Issued For Services	'	'	'	'	4,000	'
Subsequent Event [Member]	'	'	'	'	'	'
Class of Stock [Line Items]	'	'	'	'	'	'
Warrants Authorized For Issuance To Acquire Common Stock Shares Number	'	136,368	'	'	'	'
Exercise Price Of Warrants	'	$2.20	'	'	'	'
Warrants Authorized For Issuance To Acquire Common Stock Value	'	64,000	'	'	'	'
Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized	'	659,000	'	'	'	659,000
Subsequent Event [Member] | Registered Direct Offering [Member]	'	'	'	'	'	'
Class of Stock [Line Items]	'	'	'	'	'	'
Stock Issued During Period, Shares, New Issues	'	812,500	'	'	'	'
Gross Proceeds From Public Stock Offering Of Common Stock	'	6,500,000	'	'	'	'
Employee Stock Option [Member]	'	'	'	'	'	'
Class of Stock [Line Items]	'	'	'	'	'	'
Share-based Compensation Outstanding - Reserved but unissued shares under the Plan	'	565,765	359,375	359,375	359,375	565,765
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grant One in the Period	'	203,990	'	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grant Two in the Period	'	2,400	'	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price	'	$2.44	$2.20	'	'	$2.44
Stock Options Granted Estimated Fair Value On Date Of Grant	'	307,000	'	'	'	'
Allocated Share-based Compensation Expense	'	76,000	'	'	'	'
Consultant Plan [Member]	'	'	'	'	'	'
Class of Stock [Line Items]	'	'	'	'	'	'
Share-based Compensation Outstanding - Reserved but unissued shares under the Plan	'	75,000	'	'	'	75,000
Stock Issued During Period Shares Issued For Services	'	11,250	'	'	'	'
Stock Issued During Period, Value, Issued For Services	'	102,000	'	'	'	'
Equity Incentive Plan [Member]	'	'	'	'	'	'
Class of Stock [Line Items]	'	'	'	'	'	'
Share-based Compensation Outstanding - Reserved but unissued shares under the Plan	'	249,736	480,260	140,625	140,625	249,736
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price	'	$7.33	'	'	'	$7.33
Equity Incentive Plan [Member] | Subsequent Event [Member]	'	'	'	'	'	'
Class of Stock [Line Items]	'	'	'	'	'	'
Share-based Compensation Outstanding - Reserved but unissued shares under the Plan	'	114,049	249,736	'	'	114,049
Qualified Independent Underwriter Fees [Member]	'	'	'	'	'	'
Class of Stock [Line Items]	'	'	'	'	'	'
Stock Issued During Period, Value, Issued for Noncash Considerations	110,000	'	'	'	'	'
Underwriter Legal Fees [Member]	'	'	'	'	'	'
Class of Stock [Line Items]	'	'	'	'	'	'
Stock Issued During Period, Value, Issued for Noncash Considerations	125,000	'	'	'	'	'
Underwriter Expenses [Member]	'	'	'	'	'	'
Class of Stock [Line Items]	'	'	'	'	'	'
Stock Issued During Period, Value, Issued for Noncash Considerations	35,000	'	'	'	'	'
Legal Fees [Member]	'	'	'	'	'	'
Class of Stock [Line Items]	'	'	'	'	'	'
Stock Issued During Period, Value, Issued for Noncash Considerations	$822,000	'	'	'	'	'

Retirement_Plan_Details_Textua

Retirement Plan (Details Textual) (USD $)	12 Months Ended		71 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013
Retirement Plan [Line Items]	'	'	'
Defined Contribution Plan, Employer Matching Contribution, Percent of Employees Gross Pay	3.00%	2.00%	'
Defined Contribution Plan, Cost Recognized	$38,000	$24,000	$62,000

Related_Party_Transactions_Det

Related Party Transactions (Details Textual) (USD $)	2 Months Ended	12 Months Ended			47 Months Ended	71 Months Ended
	31-May-12	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2011	Dec. 31, 2013
Related Party Transaction [Line Items]	'	'	'	'	'	'
Consulting Fee	'	$103,000	$145,000	$1,000,000	'	$365,000
Compensation For Patent Work and Related Expenses	'	4,000	76,000	'	'	'
Underwriter Fees	'	1,200,000	1,200,000	300,000	'	'
Warrants Authorized For Issuance To Acquire Common Stock Shares Number	345,000	'	345,000	136,364	'	'
Exercise Price Of Warrants	$5	$5	$5	$2.20	'	'
Warrants Authorized For Issuance To Acquire Common Stock Value	128,000	128,000	128,000	'	'	'
Stock Issued During Period, Shares, Issued for Services	'	'	'	454,547	2,000	'
Share Price	'	'	'	$2.20	$2.20	'
Aggregate Consulting Fee	'	'	'	'	'	1,280,000
Stock Issued During Period, Value, Issued For Services	'	'	'	'	4,000	'
Subsequent Event [Member]	'	'	'	'	'	'
Related Party Transaction [Line Items]	'	'	'	'	'	'
Warrants Authorized For Issuance To Acquire Common Stock Shares Number	'	136,368	'	'	'	'
Exercise Price Of Warrants	'	$2.20	'	'	'	'
Warrants Authorized For Issuance To Acquire Common Stock Value	'	64,000	'	'	'	'
MDB Consulting Services [Member]	'	'	'	'	'	'
Related Party Transaction [Line Items]	'	'	'	'	'	'
Stock Issued During Period, Shares, Issued for Services	'	'	'	'	'	590,911
Stock Issued During Period, Value, Issued For Services	'	'	'	'	'	1,300,000
Number Of Stock To Be Issued Upon Conversion Of Warrants	'	'	'	'	'	481,368
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price	'	'	'	'	'	$4.21
Warrants Issued During Period Value	'	'	'	'	'	$192,000

Commitments_and_Contingencies_1

Commitments and Contingencies (Details) (USD $)	Dec. 31, 2013
Operating Leased Assets [Line Items]	'
2014	$120,000
2015	137,000
2016	141,000
2017	24,000
Operating Leases, Future Minimum Payments Due	$422,000

Commitments_and_Contingencies_2

Commitments and Contingencies (Details Textual) (USD $)	1 Months Ended	12 Months Ended		71 Months Ended
	Dec. 31, 2007	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013
Loss Contingencies [Line Items]	'	'	'	'
Rent Expense Escalation Percentage	'	3.00%	'	'
Operating Leases, Rent Expense, Net	'	'	$17,000	'
Operating Leases, Rent Expense	'	135,000	137,000	428,000
Contractual Obligation	'	300,000	'	300,000
Obligation To Pay In Common Stock At Fair Value	'	150,000	'	150,000
Employee Benefits and Share-based Compensation	'	355,000	350,000	'
Loss Contingency Right To Acquire Common Stock Denied	25,250	'	'	'
Loss Contingency Right To Acquire Common Stock Denied, Exercise Price	$0.02	'	'	'
Triple Net Operating Cost	'	2,000	'	'
Reduction In Deferred Rent	'	$4,000	'	'

Subsequent_Events_Details

Subsequent Events (Details) (USD $)	Dec. 31, 2013
Subsequent Event [Line Items]	'
Employee Service Share-Based Compensation, Nonvested Awards, Total Compensation Cost Not Yet Recognized	$290,000
Year 2014 [Member]	'
Subsequent Event [Line Items]	'
Employee Service Share-Based Compensation, Nonvested Awards, Total Compensation Cost Not Yet Recognized	116,000
Year 2015 [Member]	'
Subsequent Event [Line Items]	'
Employee Service Share-Based Compensation, Nonvested Awards, Total Compensation Cost Not Yet Recognized	97,000
Year 2016 [Member]	'
Subsequent Event [Line Items]	'
Employee Service Share-Based Compensation, Nonvested Awards, Total Compensation Cost Not Yet Recognized	76,000
Year 2017 [Member]	'
Subsequent Event [Line Items]	'
Employee Service Share-Based Compensation, Nonvested Awards, Total Compensation Cost Not Yet Recognized	1,000
Subsequent Event [Member]	'
Subsequent Event [Line Items]	'
Employee Service Share-Based Compensation, Nonvested Awards, Total Compensation Cost Not Yet Recognized	659,000
Subsequent Event [Member] | Year 2014 [Member]	'
Subsequent Event [Line Items]	'
Employee Service Share-Based Compensation, Nonvested Awards, Total Compensation Cost Not Yet Recognized	208,000
Subsequent Event [Member] | Year 2015 [Member]	'
Subsequent Event [Line Items]	'
Employee Service Share-Based Compensation, Nonvested Awards, Total Compensation Cost Not Yet Recognized	189,000
Subsequent Event [Member] | Year 2016 [Member]	'
Subsequent Event [Line Items]	'
Employee Service Share-Based Compensation, Nonvested Awards, Total Compensation Cost Not Yet Recognized	169,000
Subsequent Event [Member] | Year 2017 [Member]	'
Subsequent Event [Line Items]	'
Employee Service Share-Based Compensation, Nonvested Awards, Total Compensation Cost Not Yet Recognized	$93,000

Subsequent_Events_Details_1

Subsequent Events (Details 1) (Equity Incentive Plan [Member])	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Subsequent Event [Line Items]	'	'
Reserved but unissued shares under the Equity Incentive Plan, Opening	480,260	140,625
Increases in the number of authorized shares under the Equity Incentive Plan	5,866	360,434
Grants of stock options	-206,390	0
Stock grants	-30,000	-83,299
Reserved but unissued shares under the Equity Incentive Plan, Ending	249,736	480,260
Subsequent Event [Member]	'	'
Subsequent Event [Line Items]	'	'
Reserved but unissued shares under the Equity Incentive Plan, Opening	249,736	'
Increases in the number of authorized shares under the Equity Incentive Plan	1,818	'
Grants of stock options	-122,880	'
Stock grants	-14,625	'
Reserved but unissued shares under the Equity Incentive Plan, Ending	114,049	'

Subsequent_Events_Details_Text

Subsequent Events (Details Textual) (USD $)	47 Months Ended	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2013	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2013
		Subsequent Event [Member]	Equity Incentive Plan [Member]	Equity Incentive Plan [Member]	Equity Incentive Plan [Member]	Equity Incentive Plan [Member]
		Registered Direct Offering [Member]			Subsequent Event [Member]	Subsequent Event [Member]
						Employee [Member]
Subsequent Event [Line Items]	'	'	'	'	'	'
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Fair Value	'	'	'	'	$10.26	$9.90
Stock Granted During Period, Value, Share-Based Compensation, Gross	$275,000	'	'	'	$222,000	'
Share Base Compensation Arrangements By Share Based Payments Awards Granted	'	'	'	'	'	369,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term	'	'	'	'	'	'10 years
Stock Issued During Period, Shares, New Issues	'	812,500	'	'	'	'
Stock Issued During Period Value per Share	'	$8	'	'	'	'
Warrants to purchase common stock, Shares	'	20,313	'	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross	'	'	206,390	0	122,880	7,000
Payments for Placement Agent Legal Fees	'	75,000	'	'	'	'
Payments for Issuer Legal Fees	'	175,000	'	'	'	'
Gross Proceeds From Public Stock Offering Of Common Stock	'	6,500,000	'	'	'	'
Net Proceeds From Public Stock Offering Of Common Stock	'	5,700,000	'	'	'	'
Investment Warrants, Exercise Price	'	$10	'	'	'	'
Investment Warrants Expiration Date	'	31-Mar-19	'	'	'	'
Payments of Stock Issuance Costs	'	800,000	'	'	'	'
Placement Agent Fees	'	$500,000	'	'	'	'